These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27161253)

  • 21. Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report.
    Søndergaard CB; Scheie D; Sehested AM; Skjøth-Rasmussen J
    Childs Nerv Syst; 2017 Jul; 33(7):1217-1220. PubMed ID: 28236063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.
    Wang K; Wang Y; Fan X; Wang J; Li G; Ma J; Ma J; Jiang T; Dai J
    Neuro Oncol; 2016 Apr; 18(4):589-97. PubMed ID: 26409566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.
    Bianco AM; Uno M; Oba-Shinjo SM; Clara CA; de Almeida Galatro TF; Rosemberg S; Teixeira MJ; Nagahashi Marie SK
    Pathol Oncol Res; 2015 Apr; 21(2):229-40. PubMed ID: 24970694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
    Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
    Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.
    Kibe Y; Motomura K; Ohka F; Aoki K; Shimizu H; Yamaguchi J; Nishikawa T; Saito R
    Sci Rep; 2023 Jan; 13(1):23. PubMed ID: 36646712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
    Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.
    Kim BYS; Jiang W; Beiko J; Prabhu SS; DeMonte F; Gilbert MR; Sawaya R; Aldape KD; Cahill DP; McCutcheon IE
    J Neurooncol; 2014 Jun; 118(2):405-412. PubMed ID: 24777756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
    Kuroda J; Nobusawa S; Nakamura H; Yokoo H; Ueda R; Makino K; Yano S; Kuratsu J
    Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
    Shibahara I; Sonoda Y; Suzuki H; Mayama A; Kanamori M; Saito R; Suzuki Y; Mashiyama S; Uenohara H; Watanabe M; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2018 Jan; 35(1):10-18. PubMed ID: 29138945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.
    Moriya K; Kaneko MK; Liu X; Hosaka M; Fujishima F; Sakuma J; Ogasawara S; Watanabe M; Sasahara Y; Kure S; Kato Y
    Cancer Sci; 2014 Mar; 105(3):359-62. PubMed ID: 24344754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK; Skjulsvik AJ; Torp SH
    Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation.
    Tourne M; Tauziède-Espariat A; Dezamis E; Saffroy R; Dhermain F; Chrétien F; Varlet P
    World Neurosurg; 2018 Aug; 116():316-321. PubMed ID: 29859360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
    Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
    World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
    Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
    World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
    Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
    Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
    Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
    World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels.
    Álvarez-Torres MDM; López-Cerdán A; Andreu Z; de la Iglesia Vayá M; Fuster-Garcia E; García-García F; García-Gómez JM
    NMR Biomed; 2023 Nov; 36(11):e5004. PubMed ID: 37482922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].
    de Quintana-Schmidt C; Alvarez-Holzapfel MJ; Nomdedeu-Guinot J; Bague-Rosell S; Gallego-Rubio O; Leidinger A; Salgado-Lopez L; Molet-Teixidó J
    Neurocirugia (Astur); 2015; 26(6):276-83. PubMed ID: 26194445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma.
    Ishii T; Mizukawa K; Sasayama T; Sasaki H; Hayashi S; Nakamizo S; Tanaka H; Tanaka K; Hara S; Hirai C; Itoh T; Kohmura E
    Neuropathology; 2013 Jun; 33(3):299-305. PubMed ID: 22994265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.